Genetic translocations resulting in gene fusions are common in ALK-dependent human cancers, including non-small cell lung cancer, diffuse large B cell lymphoma, squamous cell carcinoma, and renal cell carcinoma (Hallberg and Palmer, 2013; Holla et al., 2017; Morris et al., 1994). This evidence concerns the gene ALK and hereditary clear cell renal cell carcinoma.